Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of RTVue XR With SSADA in Retinal Patients

NCT02535520 is registered in ClinicalTrials.gov with Optovue as lead sponsor.

NCT NCT02535520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02535520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of RTVue XR With SSADA in Retinal Patients
Lead sponsor
Optovue
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
December 31, 2015
Enrollment
155 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

retina vascular pathology